AIP
DYN icon

Ameritas Investment Partners’s Dyne Therapeutics DYN Stock Holding History

Ameritas Investment Partners’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$198K Buy
10,907
+465
+4% +$8.02K 0.01% 1270
2025
Q4 		$204K Buy
10,442
+860
+9% +$16.3K 0.01% 1240
2025
Q3 		$121K Hold
9,582
– – ﹤0.01% 1563
2025
Q2 		$91.2K Buy
9,582
+955
+11% +$10.5K ﹤0.01% 1819
2025
Q1 		$90.2K Hold
8,627
– – ﹤0.01% 1776
2024
Q4 		$203K Buy
8,627
+721
+9% +$21.3K 0.01% 1313
2024
Q3 		$284K Hold
7,906
– – 0.01% 1111
2024
Q2 		$279K Buy
7,906
+2,010
+34% +$58.4K 0.01% 1051
2024
Q1 		$167K Buy
5,896
+1,291
+28% +$29.2K 0.01% 1410
2023
Q4 		$61.2K Buy
4,605
+1,095
+31% +$10.7K ﹤0.01% 2044
2023
Q3 		$31.4K Hold
3,510
– – ﹤0.01% 2332
2023
Q2 		$39.5K Buy
3,510
+1,155
+49% +$13.6K ﹤0.01% 2188
2023
Q1 		$27.1K Hold
2,355
– – ﹤0.01% 2334
2022
Q4 		$32.1K Hold
2,355
– – ﹤0.01% 2323
2022
Q3 		$29K Hold
2,355
– – ﹤0.01% 2320
2022
Q2 		$16K Hold
2,355
– – ﹤0.01% 2647
2022
Q1 		$23K Hold
2,355
– – ﹤0.01% 2489
2021
Q4 		$28K Hold
2,355
– – ﹤0.01% 2476
2021
Q3 		$38K Hold
2,355
– – ﹤0.01% 2336
2021
Q2 		$50K Buy
2,355
+1,163
+98% +$21.9K ﹤0.01% 2179
2021
Q1 		$19K Hold
1,192
– – ﹤0.01% 2585
2020
Q4 		$25K Buy
+1,192
New +$23.6K ﹤0.01% 2352

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

Ameritas Investment Partners's DYN Position: Q1 2026 in Review

Ameritas Investment Partners increased its Dyne Therapeutics (DYN) stake by 4.5% in Q1 2026, buying an estimated $8.02K and bringing the position to 10,907 shares worth $198K. The position accounts for 0.01% of the portfolio, ranked #1270.

Ameritas Investment Partners first reported a position in DYN in Q4 2020 and has held it in 22 quarters since. The position peaked at $284K in Q3 2024. 227 funds tracked by Wall St. Rank hold DYN as of Q1 2026.

  • Ameritas Investment Partners held 10,907 shares of Dyne Therapeutics worth $198K as of Q1 2026.
  • Ameritas Investment Partners bought 465 Dyne Therapeutics shares in Q1 2026, an estimated $8.02K.
  • Dyne Therapeutics made up 0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #1270 holding.
  • Ameritas Investment Partners first reported a position in Dyne Therapeutics in Q4 2020 and has held it in 22 quarters since.
  • Ameritas Investment Partners's Dyne Therapeutics position peaked at $284K in Q3 2024.
  • 227 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.